EUVIMEDEUVIMED entdecken
Crossref

Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025

Mathieu Bernard, Benoit Dumont, Guillaume Penaranda iD, Pablo Ruiz, Mickael Fortun, Nicolas Martin, Vincent Vieillefond, Jérémie Corneille, Sophie Levy, Hélène Beaussier

Sexual Health · 2026

DOI: 10.1071/sh26127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sexual Health, 2026. Verfasst von Mathieu Bernard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biogroup Côte d'Azur, Sanary sur mer, France. Hauptthemen laut MEDLINE: Chlamydia Infections, Chlamydia trachomatis, Mass Screening. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In France, Chlamydia trachomatis (Ct) infections have steadily increased since the late 1990s, particularly among young adults. To improve access to screening, the national prescription-free testing program, ‘Mon Test IST’ (MTI), was introduced in 2024, providing direct and largely reimbursed screening for five sexually transmitted infections in private laboratories. This study aimed to estimate Ct test positivity in 2025 within the Biogroup laboratory network and to identify factors associated with the use of the MTI program, with a particular focus on individuals aged between 18 and 25 years, inclusive.

Methods

Within the MTI pathway, a standardized questionnaire collected information on symptoms, risk factors and sexual practices, allowing adaptation of sampling sites (systematic urogenital testing with additional pharyngeal and/or anal sampling when relevant). Pseudonymized data from >900 Biogroup laboratories (approximately 25% of the French private medical laboratory sector) were extracted for 2025 across five major regions. Analyses included descriptive statistics, chi-squared tests and logistic regression with a significance level of 0.05.

Results

In 2025, 313,585 screenings were performed with a prescription and 230,022 through MTI. MTI was used by 56.3% of patients aged 18–25 years compared with 34.6% of patients aged ≥26 years (P < 0.0001). Young men were more likely than young women to use the prescription-free pathway (61.6% vs 52.6%; OR 1.45, 95% CI 1.42–1.48). Overall Ct test positivity was 5.1%, reaching 8.1% in individuals aged 18–25 years. Among asymptomatic young individuals without reported risk factors, Ct test positivity remained notable (4.4% in women, 3.9% in men). In multi-site testing, 13.3% of infections would have been missed with urogenital sampling alone.

Conclusion

The MTI program effectively reaches young individuals with high Ct test positivity, including those who do not perceive themselves at risk. Prescription-free access combined with practice-adapted sampling appears to be a valuable strategy to strengthen Ct screening in France.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydia InfectionsChlamydia trachomatisMass ScreeningHumansFranceFemaleMaleAdolescentAdultYoung AdultRisk FactorsSurveys and Questionnaires

Stichwörter der Autor:innen

Chlamydia trachomatis prevalenceMon Test ISTasymptomatic infectionscommunity laboratoryextragenital screeninglaboratory surveillanceprescription-free testingreal-world datasexually transmitted infection screeningtest positivityyoung adults

Autor:innen und Institutionen

  • Biogroup Côte d'Azur, Sanary sur mer, France.
  • Biogroup Rhône Alpes, Meylan, France.
  • Biogroup Technologies, Marselle, France.
  • Biogroup Paris Ouest, Paris, France.
  • Biogroup Bretagne, Carquefou, France.
  • Biogroup SCM, Paris, France.

ORCID-Profile: Guillaume Penaranda

Zitieren

APA

Bernard, M., Dumont, B., Penaranda, G., Ruiz, P., Fortun, M., Martin, N., Vieillefond, V., Corneille, J., Levy, S., & Beaussier, H. (2026). Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025. Sexual Health. https://doi.org/10.1071/sh26127

Vancouver

Bernard M, Dumont B, Penaranda G, Ruiz P, Fortun M, Martin N, et al. Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025. Sexual Health. 2026. doi:10.1071/sh26127

BibTeX
@article{Bernard2026,
  author = {Bernard, Mathieu and Dumont, Benoit and Penaranda, Guillaume and Ruiz, Pablo and Fortun, Mickael and Martin, Nicolas and Vieillefond, Vincent and Corneille, Jérémie and Levy, Sophie and Beaussier, Hélène},
  title = {Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025},
  journal = {Sexual Health},
  year = {2026},
  doi = {10.1071/sh26127}
}
Kostenlos starten →